Observational Study of Control Participants for the MAPP Research Network



Status:Recruiting
Conditions:Fibromyalgia, Irritable Bowel Syndrome (IBS), Neurology, Pain
Therapuetic Areas:Gastroenterology, Musculoskeletal, Neurology, Rheumatology
Healthy:No
Age Range:18 - Any
Updated:2/7/2015
Start Date:December 2009
Contact:Nancy Robinson, PhD
Email:narobins@mail.med.upenn.edu

Use our guide to learn which trials are right for you!

Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Control Study

The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain
(MAPP) Research Network has been established to focus on a broader approach to the study of
Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic
Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men, than previously undertaken.

Participants with no Urologic Pelvic Pain Syndromes as well as participants with specific
conditions (Fibromyalgia (FM), Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome
(CFS)) are being recruited for the Trans-MAPP Control Study. These participants will act as
a reference/control group for the Trans-MAPP Epidemiology & Phenotyping (EP) Study.

As with many chronic pain disorders, IC and CP are poorly understood, and treatment is often
not helpful. The goal of this study is to better understand how pain is felt in people with
IC or CP. The MAPP Control Study is an observational study that will enroll participants
from 6 Discovery Sites and 3 Satellite Sites across the U.S. The investigators will ask
questions and gather information about the health and life of the participants for research
purposes. The investigators hope that this study will lead to improvement in the treatment
of IC and CP.

Trans-MAPP Control participants will only need to complete one study visit to collect
baseline data and biospecimens. Potential participants will be scheduled for an eligibility
screening session. Following screening, potentially eligible participants will complete a
baseline phenotyping session, and biospecimen collections, which together are expected to
take approximately 2.5 hours to complete. Participants will be provided with breaks as
needed during the clinic visit.

The eligibility criteria for both healthy controls and positive controls are based on the
same set of criteria for the Urologic Chronic Pelvic Pain Syndrome (UCPPS) participants in
the Trans-MAPP EP Study, with exception of additional criteria to exclude chronic pelvic
pain symptoms and criteria to identify the co-morbid syndromes for the positive controls.
All entry criteria are shown below; those specific to either healthy or positive control
participants are so indicated.

Inclusion Criteria:

Participants are eligible for the Trans-MAPP Control Protocol if they meet the following
general and gender-specific criteria listed below:

1. Participant has signed and dated the appropriate Informed Consent document.

2. Agreed to participate in Trans-MAPP Control Study procedures;

Inclusion Criteria for Healthy Controls only

1. Participant reports a response of "0" (zero) on the pain, pressure or discomfort
scale.

2. Participant reports no chronic pain in the pelvic or bladder region, and reports
chronic pain in no more than one other body region.

3. Participant reports no urological symptoms that have been evaluated, but are still
present.

Inclusion Criteria for Positive Controls only:

1. Participant meets the validated criteria for one or more of the following conditions

1. Fibromyalgia (FM)

2. Irritable bowel syndrome (IBS)

3. Chronic fatigue syndrome (CFS)

Exclusion Criteria:

Individuals will not be eligible for enrollment in the Trans-MAPP Control Study if they
meet any of the criteria:

1. Participant has an on-going symptomatic urethral stricture.

2. Participant has an on-going neurological disease or disorder affecting the bladder or
bowel fistula.

3. Participant has a history of cystitis caused by tuberculosis or radiation therapy or
Cytoxan/cyclophosphamide therapy.

4. Participant has augmentation cystoplasty or cystectomy.

5. Participant has a systemic autoimmune disorder (such as Crohn's Disease, Ulcerative
Colitis, Lupus, Rheumatoid Arthritis, or Multiple Sclerosis).

6. Participant has a history of cancer (with the exception of skin cancer).

7. Participant has current major psychiatric disorder or other psychiatric or medical
issues that would interfere with study participation (e.g. dementia, psychosis,
upcoming major surgery, etc).

8. Participant has severe cardiac, pulmonary, renal, or hepatic disease that in the
judgment of the study physician would preclude participation in this study.

Exclusion Criteria for Males Only

1. Male participant diagnosed with unilateral orchialgia, without pelvic symptoms.

2. Male participant has a history of transurethral microwave thermotherapy (TUMT),
transurethral needle ablation (TUNA), balloon dilation, or prostate cryosurgery or
laser procedure.

Exclusion Criteria for Females Only:

1) Female participant has a history of High-Grade Squamous Intraepithelial Lesion (HGSIL)
/ high-grade cervical dysplasia.
We found this trial at
8
sites
Los Angeles, California 90095
310-825-4321
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
201 East Huron Street
Chicago, Illinois 60611
(847) 491-3741
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
University of Iowa With just over 30,000 students, the University of Iowa is one of...
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
Seattle, Washington 98104
(206) 543-2100
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
St Louis, Missouri 63110
?
mi
from
St Louis, MO
Click here to add this to my saved trials
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials